Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 251-275 of 1083 results.
{{ selectedCountPage }} items selected on this page,{{ selectedCountPage }} item selected on this page,{{ selectedCountTotal }} item in total{{ selectedCountTotal }} items in total
Study aim:
Determination of plasmapheresis effect and plasma replacement in patients with covid19(...) between 8 to 16 years
2.COVID-19 positive
3. interleukin above 6
4.Patients hospitalized in the (...) lips
6.Oxygen saturation percentage ≤93%
7-Patients with covid-19 disease receiving antiretroviral
of patients with COVID-19 infection in Arak city in 2020
Design:
Clinical trials with a control (...)COVID-19.
Settings and conduct:
The study is performed at Corona Patients ward of Ayatollah Khansari (...) who are hospitalized in the ward and are considered to have a moderate case of COVID-19 (need to be
Study aim:
Evaluation of the effect of herbal oral product (thyme syrup) in patients with COVID-19
Design:
152 patients between the ages of 30 and 65 with a probable diagnosis of COVID-19 according to the (...) Imam Khomeini Hospital in Sari are diagnosed with COVID-19 manifestation will entered. Then, 152
severe pneumonia related to COVID-19
Design:
This study is a single-center, prospective, randomized (...) :
Inclusion criteria: confirmed diagnosis of COVID-19; the written consciously and freely consent to (...) reaction to glucocorticoids; recent hospitalization due to COVID-19; receive antivirals before inclusion
between the ages of 18 and 75 with a probable diagnosis of COVID-19 based on national protocol, after (...)COVID-19 based on the protocol of Iran
exclusion criteria: comorbidity, pregnancy and lactation, history (...) treatment for COVID-19 + hot cupping is 4 cm (T4) on each side of the vertebrae, 4 cm from the spinus
Study aim:
The effect of Rosa Damascena extract in treatment of COVID-19 patients in kosar hospital (...) 10 patients with COVID-19 who will be consequently admitted to semnan hospital. The patients will (...) :
Patients with COVID-19 who are older than 18 years old
Intervention groups:
Intervention group: To 10
Disease (COVID-19) in patients with cancer.
Design:
This is a two-arm, parallel-group, triple-blind (...) will be monitored for COVID-19 symptoms. If signs or symptoms occur (fever, cough, shortness of breath (...) disease.
Acute respiratory tract infection in the last 2 month.
Having COVID-19 in the first two weeks of
Study aim:
Evaluation of trans sodium crocetinate spray in COVID-19 patients
Design:
A randomized (...) patients with covid-19 disease were selected and randomly assigned to two groups of 15 individuals (...) criteria:Patients with clinical diagnosis for Covid-19 disease, Patients with acute respiratory distress syndrome
coronavirus pneumonia (COVID-19)
Design:
A randomized controlled clinical trial with parallel groups (...)Covid-19, and candidate for quarantine and receive home treatment will enter to the study.
Patients in (...) exclusion criteria:
Patients with 18-65 years old, developing mild to moderate COVID-19 based on Ministry of
clinical, vital sign and laboratory results in patients with COVID-19
Design:
This study is a prospective (...) hospital in separated period of time and received national therapeutic guideline of COVID19 without (...) suspected or definitely diagnosed with COVID19 and candidate receiving recommended therapeutic regimen
outpatients suspected COVID-19 in Kerman medical centers
Design:
A randomized controlled clinical trial with (...) Corona Virus Guideline who visit the clinics designated by the Kerman department of Health for COVID-19(...) :
Patients with 18-65 years old, developing mild to moderate COVID-19 based on Ministry of Health protocol
in covid-19 patients
Design:
A randomized and open controlled clinical trial with a parallel group (...) will be performed on inpatients. In this study, 30 patients with covid-19 disease were selected and (...) exclusion criteria:
Inclusion criteria: patients with clinical diagnosis for Covid-19 disease; patients with
)) compared with Hydroxy chlorquine on the of mortality rate in patients with moderate symptoms of COVID-19(...)COVID-19 with moderate symptoms. Patients with the inclusion criteria will be randomly assigned to the (...) exclusion criteria:
Inclusion criteria: age range within 18 to 65; definitive diagnosis with COVID-19 with
severity of COVID-19 symptoms in outpatients referred to clinic with a positive result of lung CT scan (...) questionnaire and interview, checklist , CT scan and physical examination the patients with COVID-19 symptoms (...) exclusion criteria:
Inclusion Criteria: Pulmonary involvement on CT scan suspected to covid-19 disease
Study aim:
Determining the effect of information support on resilience, fear and anxiety of patients with Covid19
Design:
Clinical trial with experimental and control groups, with parallel groups (...) has been 48 hours since the patient was admitted. Definitive diagnosis of Covid19 by an infectious
COVID-19 and the necessary follow-ups and Covid test -19 will be performed.
Participants/Inclusion and (...) live vaccine, or testing positive for COVID-19.
Intervention groups:
MMR vaccine injection to the study group
Main outcome variables:
Comparison of the incidence of Covid-19 disease in the vaccinated
Randomization.com online software for randomization.
Settings and conduct:
In this study, patients with Covid19(...) , pregnancy
Intervention groups:
In the intervention group, 40 patients with Covid receive 19 omega-3 (...) per day for 5 days. In the control group, 40 patients with Covid19 receive 5 placebo capsules similar
control groups in hospitalized patients with COVID-19
Design:
A randomized controlled clinical trial (...) of Kamkar Martyrs Hospital in Qom; Study population: hospitalized patients with COVID-19 ; Type of (...) :
Inclusion criteria: patients with COVID-19; Ability to participate in the study; Age between 18 and 70
Study aim:
Evaluation of the therapeutic effect of Molnupiravir in COVID-19 patients with moderate (...) and conduct:
This study was performed on patients with moderate COVID-19 referred to the infectious (...) : Laboratory confirmation of Coronavirus disease-19 (COVID-19) virus by reverse transcription- polymerase chain
:
Place of study: Masih Daneshvari Hospital. How to do the study: 120 patients with COVID-19, using (...) 100 years old who have laboratory confirmed COVID-19 (Corona Virus Disease-19) with RT-PCR (Real-Time
inflammatory factors and acute phase lipid and protein profiles in patients with Covid - 19 hospitalized (...) with Covid-19 in the age range of 20 to 70 years who are admitted to the covid-19 ward of Khatam al (...) criteria:
At first, all patients with Covid-19 in the age range of 20 to 70 years who are admitted to the
Study aim:
Evaluation of the effect of Tocilizumab on outcomes of the severe COVID-19 patients
Design:
The patients become divided in two groups by using block randomization. One group receive (...) exclusion criteria:
Study entry requirements:
covid-19 disease confirmed by chest ct and PCR
no pregnancy
no
Study aim:
Treatment of of COVID-19 patients by shallomin syrup
Design:
This parallel-group, double-blind, and the randomized controlled trial is randomized by designing a table using blocks of (...) criteria:
Inclusion criteria: COVIDE-19 patients who show specified COVIDE-19 clinical symptoms; positive
radiology- symptoms remission
Design:
The confirmed and suspicious COVID-19 patients who have been admitted (...) 200 mg of hydroxychloroquine every 12 hours as the main treatment of COVID-19. Then, the pharmacist (...) :
The consent to participate
The confirmed and suspicious COVID-19 patients
Not participating in other
and hospitalizations in suspected COVID-19 outpatient cases
Design:
Controlled clinical trial with (...) criteria
suspected COVID-19 outpatient cases according to the flowchart for the Diagnosis and Treatment of 19COVID Diseases of the Ministry of Health, Age between 18 and 65 years, Signing a Informed Consent